This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Helt, A.-M.
Right arrow Articles by Galloway, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Helt, A.-M.
Right arrow Articles by Galloway, D. A.

Next Article 

Journal of Virology, August 2001, p. 6737-6747, Vol. 75, No. 15
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.15.6737-6747.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Destabilization of the Retinoblastoma Tumor Suppressor by Human Papillomavirus Type 16 E7 Is Not Sufficient To Overcome Cell Cycle Arrest in Human Keratinocytes

Anna-Marija Helt and Denise A. Galloway*

Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, and Department of Microbiology, University of Washington, Seattle, Washington 98195

Received 9 February 2001/Accepted 27 April 2001

The E7 oncoprotein of human papillomavirus type 16 promotes cell proliferation in the presence of antiproliferative signals. Mutagenesis of E7 has revealed that this activity requires three regions, conserved regions 1 and 2 and a C-terminal zinc finger. Binding to the retinoblastoma tumor repressor (Rb) through an LxCxE motif in conserved region 2 is necessary, but not sufficient, for E7 to induce proliferation. We tested the hypothesis that binding to Rb is not sufficient because conserved region 1 and/or the C terminus are required for E7 to functionally inactivate Rb and thus induce proliferation. One mechanism proposed for how E7 inactivates Rb is by blocking Rb-E2F binding. Either conserved region 1 or the C terminus was necessary, in combination with the LxCxE motif, for E7 to block Rb-E2F binding in vitro. While all full-length E7 proteins with mutations outside of the LxCxE motif inhibited Rb-E2F binding, some failed to abrogate cell cycle arrest, demonstrating that blocking Rb-E2F binding is not sufficient for abrogating antiproliferative signals. Another mechanism proposed for how E7 inactivates Rb is by promoting the destabilization of Rb protein. Mutations in conserved region 1 or the LxCxE motif prevented E7 from reducing the half-life of Rb. Though no specific C-terminal residues of E7 were essential for destabilizing Rb, a novel class of mutations that uncouple the destabilization of Rb from the deregulation of keratinocyte proliferation was discovered. Destabilization of Rb correlated with the abrogation of Rb-induced quiescence but was not sufficient for overriding DNA damage-induced cell cycle arrest or for increasing keratinocyte life span. Finally, the same regions of E7 required for destabilizing Rb were required for reducing p107 and p130 levels. Together, these results suggest that inactivation of all three Rb family members is not sufficient to deregulate keratinocyte cell cycle control.

* Corresponding author. Mailing address: Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., Mailstop C1-015, Seattle, WA 98109. Phone: (206) 667-4500. Fax: (206) 667-5815. E-mail: dgallowa{at}fhcrc.org.

Journal of Virology, August 2001, p. 6737-6747, Vol. 75, No. 15
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.15.6737-6747.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Spardy, N., Covella, K., Cha, E., Hoskins, E. E., Wells, S. I., Duensing, A., Duensing, S. (2009). Human Papillomavirus 16 E7 Oncoprotein Attenuates DNA Damage Checkpoint Control by Increasing the Proteolytic Turnover of Claspin. Cancer Res. 69: 7022-7029 [Abstract] [Full Text]  
  • Shin, M.-K., Balsitis, S., Brake, T., Lambert, P. F. (2009). Human Papillomavirus E7 Oncoprotein Overrides the Tumor Suppressor Activity of p21Cip1 in Cervical Carcinogenesis. Cancer Res. 69: 5656-5663 [Abstract] [Full Text]  
  • Wise-Draper, T. M., Mintz-Cole, R. A., Morris, T. A., Simpson, D. S., Wikenheiser-Brokamp, K. A., Currier, M. A., Cripe, T. P., Grosveld, G. C., Wells, S. I. (2009). Overexpression of the Cellular DEK Protein Promotes Epithelial Transformation In vitro and In vivo. Cancer Res. 69: 1792-1799 [Abstract] [Full Text]  
  • Lin, Z., Bazzaro, M., Wang, M.-C., Chan, K. C., Peng, S., Roden, R. B.S. (2009). Combination of Proteasome and HDAC Inhibitors for Uterine Cervical Cancer Treatment. Clin. Cancer Res. 15: 570-577 [Abstract] [Full Text]  
  • Lin, C.-H., Chang, H.-S., Yu, W. C. Y. (2008). USP11 Stabilizes HPV-16E7 and Further Modulates the E7 Biological Activity. J. Biol. Chem. 283: 15681-15688 [Abstract] [Full Text]  
  • Bedard, K. M., Underbrink, M. P., Howie, H. L., Galloway, D. A. (2008). The E6 Oncoproteins from Human Betapapillomaviruses Differentially Activate Telomerase through an E6AP-Dependent Mechanism and Prolong the Lifespan of Primary Keratinocytes. J. Virol. 82: 3894-3902 [Abstract] [Full Text]  
  • Spardy, N., Duensing, A., Charles, D., Haines, N., Nakahara, T., Lambert, P. F., Duensing, S. (2007). The Human Papillomavirus Type 16 E7 Oncoprotein Activates the Fanconi Anemia (FA) Pathway and Causes Accelerated Chromosomal Instability in FA Cells. J. Virol. 81: 13265-13270 [Abstract] [Full Text]  
  • Huh, K., Zhou, X., Hayakawa, H., Cho, J.-Y., Libermann, T. A., Jin, J., Wade Harper, J., Munger, K. (2007). Human Papillomavirus Type 16 E7 Oncoprotein Associates with the Cullin 2 Ubiquitin Ligase Complex, Which Contributes to Degradation of the Retinoblastoma Tumor Suppressor. J. Virol. 81: 9737-9747 [Abstract] [Full Text]  
  • Balsitis, S., Dick, F., Dyson, N., Lambert, P. F. (2006). Critical Roles for Non-pRb Targets of Human Papillomavirus Type 16 E7 in Cervical Carcinogenesis. Cancer Res. 66: 9393-9400 [Abstract] [Full Text]  
  • Gammoh, N., Grm, H. S., Massimi, P., Banks, L. (2006). Regulation of Human Papillomavirus Type 16 E7 Activity through Direct Protein Interaction with the E2 Transcriptional Activator. J. Virol. 80: 1787-1797 [Abstract] [Full Text]  
  • Zhang, B., Chen, W., Roman, A. (2006). The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation. Proc. Natl. Acad. Sci. USA 103: 437-442 [Abstract] [Full Text]  
  • Collins, A. S., Nakahara, T., Do, A., Lambert, P. F. (2005). Interactions with Pocket Proteins Contribute to the Role of Human Papillomavirus Type 16 E7 in the Papillomavirus Life Cycle. J. Virol. 79: 14769-14780 [Abstract] [Full Text]  
  • Balsitis, S., Dick, F., Lee, D., Farrell, L., Hyde, R. K., Griep, A. E., Dyson, N., Lambert, P. F. (2005). Examination of the pRb-Dependent and pRb-Independent Functions of E7 In Vivo. J. Virol. 79: 11392-11402 [Abstract] [Full Text]  
  • Huh, K.-W., DeMasi, J., Ogawa, H., Nakatani, Y., Howley, P. M., Munger, K. (2005). Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600. Proc. Natl. Acad. Sci. USA 102: 11492-11497 [Abstract] [Full Text]  
  • Bischof, O., Nacerddine, K., Dejean, A. (2005). Human Papillomavirus Oncoprotein E7 Targets the Promyelocytic Leukemia Protein and Circumvents Cellular Senescence via the Rb and p53 Tumor Suppressor Pathways. Mol. Cell. Biol. 25: 1013-1024 [Abstract] [Full Text]  
  • GALLOWAY, D.A., GEWIN, L.C., MYERS, H., LUO, W., GRANDORI, C., KATZENELLENBOGEN, R.A., McDOUGALL, J.K. (2005). Regulation of Telomerase by Human Papillomaviruses. Cold Spring Harb Symp Quant Biol 70: 209-215 [Abstract]  
  • Munger, K., Baldwin, A., Edwards, K. M., Hayakawa, H., Nguyen, C. L., Owens, M., Grace, M., Huh, K. (2004). Mechanisms of Human Papillomavirus-Induced Oncogenesis. J. Virol. 78: 11451-11460 [Full Text]  
  • Gewin, L., Myers, H., Kiyono, T., Galloway, D. A. (2004). Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex. Genes Dev. 18: 2269-2282 [Abstract] [Full Text]  
  • Psyrri, A., DeFilippis, R. A., Edwards, A. P. B., Yates, K. E., Manuelidis, L., DiMaio, D. (2004). Role of the Retinoblastoma Pathway in Senescence Triggered by Repression of the Human Papillomavirus E7 Protein in Cervical Carcinoma Cells. Cancer Res. 64: 3079-3086 [Abstract] [Full Text]  
  • Longworth, M. S., Laimins, L. A. (2004). The Binding of Histone Deacetylases and the Integrity of Zinc Finger-Like Motifs of the E7 Protein Are Essential for the Life Cycle of Human Papillomavirus Type 31. J. Virol. 78: 3533-3541 [Abstract] [Full Text]  
  • Balsitis, S. J., Sage, J., Duensing, S., Munger, K., Jacks, T., Lambert, P. F. (2003). Recapitulation of the Effects of the Human Papillomavirus Type 16 E7 Oncogene on Mouse Epithelium by Somatic Rb Deletion and Detection of pRb-Independent Effects of E7 In Vivo. Mol. Cell. Biol. 23: 9094-9103 [Abstract] [Full Text]  
  • Bisht, K. S., Bradbury, C. M., Mattson, D., Kaushal, A., Sowers, A., Markovina, S., Ortiz, K. L., Sieck, L. K., Isaacs, J. S., Brechbiel, M. W., Mitchell, J. B., Neckers, L. M., Gius, D. (2003). Geldanamycin and 17-Allylamino-17-demethoxygeldanamycin Potentiate the in Vitro and in Vivo Radiation Response of Cervical Tumor Cells via the Heat Shock Protein 90-Mediated Intracellular Signaling and Cytotoxicity. Cancer Res. 63: 8984-8995 [Abstract] [Full Text]  
  • He, W., Staples, D., Smith, C., Fisher, C. (2003). Direct Activation of Cyclin-Dependent Kinase 2 by Human Papillomavirus E7. J. Virol. 77: 10566-10574 [Abstract] [Full Text]  
  • Helt, A.-M., Galloway, D. A. (2003). Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins. Carcinogenesis 24: 159-169 [Abstract] [Full Text]  
  • Zhao, L., Samuels, T., Winckler, S., Korgaonkar, C., Tompkins, V., Horne, M. C., Quelle, D. E. (2003). Cyclin G1 Has Growth Inhibitory Activity Linked to the ARF-Mdm2-p53 and pRb Tumor Suppressor Pathways. Mol Cancer Res 1: 195-206 [Abstract] [Full Text]  
  • Lee, D., Lim, C., Seo, T., Kwon, H., Min, H., Choe, J. (2002). The Viral Oncogene Human Papillomavirus E7 Deregulates Transcriptional Silencing by Brm-related Gene 1 via Molecular Interactions. J. Biol. Chem. 277: 48842-48848 [Abstract] [Full Text]  
  • Helt, A.-M., Funk, J. O., Galloway, D. A. (2002). Inactivation of both the Retinoblastoma Tumor Suppressor and p21 by the Human Papillomavirus Type 16 E7 Oncoprotein Is Necessary To Inhibit Cell Cycle Arrest in Human Epithelial Cells. J. Virol. 76: 10559-10568 [Abstract] [Full Text]  
  • Dick, F. A., Dyson, N. J. (2002). Three Regions of the pRB Pocket Domain Affect Its Inactivation by Human Papillomavirus E7 Proteins. J. Virol. 76: 6224-6234 [Abstract] [Full Text]  
  • Noya, F., Chien, W.-M., Wu, X., Banerjee, N. S., Kappes, J. C., Broker, T. R., Chow, L. T. (2002). The Promoter of the Human Proliferating Cell Nuclear Antigen Gene Is Not Sufficient for Cell Cycle-dependent Regulation in Organotypic Cultures of Keratinocytes. J. Biol. Chem. 277: 17271-17280 [Abstract] [Full Text]  
  • Hwang, S. G., Lee, D., Kim, J., Seo, T., Choe, J. (2002). Human Papillomavirus Type 16 E7 Binds to E2F1 and Activates E2F1-driven Transcription in a Retinoblastoma Protein-independent Manner. J. Biol. Chem. 277: 2923-2930 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»